Cryptococcus neoformans & Fungal Meningitis - Complete NotesAgents of Fungal Meningitis

Common causes:

  1. Cryptococcus neoformans (most common, especially in HIV)

  2. Candida albicans (rarely causes meningitis)

  3. Opportunistic fungi: Aspergillus, Mucor

General Properties of Cryptococcus neoformansClassification & Morphology

  • Kingdom: Fungi (yeast-like fungus)

  • Morphology:

    • Round to oval budding yeast

    • Thick polysaccharide capsule (MAJOR virulence factor)

    • Narrow-based budding

Habitat

  • Ubiquitous in environment

  • Found in soil contaminated with pigeon droppings

  • Other reservoir: Birds

Pathogenic Properties

  • Facultative intracellular pathogen

  • Strong neurotropism (affinity for CNS)

  • Causes subacute/chronic meningoencephalitis

  • Opportunistic infection (primarily in immunocompromised)

Pathogenesis - Detailed Flow

1. Acquisition & Entry

  • Organism acquired by inhalation from environment

  • Yeast spores deposited into pulmonary alveoli

2. Pulmonary Phase

  • Must survive:

    • Normal to high pH

    • Physiological CO₂ concentrations

  • Phagocytized by alveolar macrophages (acidic environment)

  • Glucosylceramide synthase = essential factor for survival in extracellular environment

  • Dissemination occurs after latent period of containment in lung lymph nodes

3. Host Immune Response

  • Both cellular and humoral components involved

  • Natural killer cells and antibody-dependent cell-mediated killing

  • In immunocompromised: defective immunity allows dissemination

4. CNS Invasion

  • Strong affinity for central nervous system (neurotropism)

  • Facilitated by cryptococcal-specific factors:

    • Metalloproteinases: increase blood-brain barrier permeability

    • Urease enzymes: cause neuromodulation

    • Mechanisms for survival in nutrient-deprived brain environment

5. Meningeal Involvement

  • Causes dilation of perivascular spaces

  • Mucous and gelatinous material produced

  • Forms "soap bubble" appearance on MRI (basal ganglia)

  • Can form small contrast-enhancing lesions

Key Virulence Factors (CARNAGE Mnemonic)

C - Capsulated yeast (major virulence factor) A - AIDS-associated opportunistic infection R - Respiratory symptoms: cough, dyspnea, chest pain N - Neurotropism; Nigrosine/India ink staining highlights capsule A - Avirulent in immunocompetent (often asymptomatic) G - Glucosylceramide synthase (lung survival) & Granulomatous response E- Environmental prevalence (pigeon droppings); Entry via inhalation

Additional Virulence Mechanisms

  • Capsule formation and thickening

  • Melanin production (laccase enzyme on bird seed agar)

  • Titan cells: >10 µm, high ploidy, thick cell wall, highly crosslinked capsule

  • Efflux pumps: increased expression for drug resistance

  • Genetic plasticity: aneuploidy, hypermutator strains, transposon movement

Predisposing Factors (Risk Groups)HIV-related (Most Common)

  • HIV/AIDS patients (especially CD4 < 100 cells/μL)

Non-HIV-related

  • Patients under immunosuppressive treatments

  • Organ transplants

  • Chronic steroid therapy

  • Innate immunological problems

  • Common variable immunodeficiency syndrome

  • Hematological disorders (lymphoma, leukemia)

  • Organic failure syndromes

Clinical ManifestationsCryptococcal Meningitis (Subacute/Chronic Meningoencephalitis)

Duration of symptoms:

  • HIV cases: 1-2 weeks from onset to presentation

  • Non-HIV cases: 6-12 weeks

Neurological symptoms:

  • Headache (most common)

  • Altered mental status

  • Lethargy

  • Fever, stiff neck (with aggressive inflammatory response)

  • Nausea and vomiting

  • HIV-positive patients: may have minimal/nonspecific symptoms

Visual symptoms:

  • Early: Diplopia, photophobia

  • Late: Reduced acuity (due to high CSF pressure or optic nerve compression)

Other findings:

  • Hearing defects

  • Ataxia

  • Aphasia

  • Seizures

  • Chorea

Other Clinical Manifestations (Non-CNS)

Pulmonary:

  • Asymptomatic or mild pneumonia

  • Cough, fever, chest pain, dyspnea

  • Lung nodules

Cutaneous:

  • Papules, nodules, ulcers

  • Molluscum-contagiosum-like lesions (marker of dissemination)

Disseminated disease:

  • Fungemia with multi-organ involvement (common in HIV/AIDS)

Other sites:

  • Bone & joint: Osteomyelitis, septic arthritis

  • Ocular: Chorioretinitis, visual impairment

  • Lymph nodes: Lymphadenitis

  • Genitourinary (rare): Prostatitis, renal involvement

Laboratory DiagnosisSpecimen Collection

  • Primary: CSF

  • Additional: Blood, sputum

CSF Findings

  • Appearance: Clear → slightly turbid

  • Opening pressure: ↑ (INCREASED)

  • Protein: ↑ (ELEVATED)

  • Glucose: Normal or ↓ (DECREASED)

  • Cells: Mild pleocytosis, predominantly lymphocytes

Direct Microscopy

India ink / Nigrosine staining (Negative staining)

  • Demonstrates capsule (clear halo around yeast)

  • Positive in:

    • 70-90% of AIDS patients

    • Only ~50% of non-AIDS patients

  • Shows encapsulated budding yeast

Gram stain:

  • Gram-positive yeast

Antigen Detection (MOST SENSITIVE)

  • Capsular polysaccharide antigen in CSF/serum

  • Methods: LA (Latex Agglutination), ELISA, IF, RIA

  • Gold standard for diagnosis

Culture

Sabouraud's Dextrose Agar (SDA):

  • Mucoid creamy colonies

Bird seed (Niger seed) agar:

  • Brown pigment production (laccase enzyme)

CGB agar (for speciation):

  • C. gattii → Blue

  • C. neoformans → No color change

Biochemical Tests

  • Urease positive

  • Nitrate assimilation

  • Growth at 37°C

Molecular

  • PCR for confirmation/speciation

Histopathology

  • Mucicarmine stain: Inner layer of yeast capsule stains red

  • Shows widened alveolar septum with inflammatory cells and numerous yeasts

Imaging (MRI)

  • Small contrast-enhancing lesions (basal ganglia)

  • Cyst-like lesions with "soap bubble appearance"

  • Caused by dilation of perivascular spaces due to mucous/gelatinous material

Antifungal Resistance Mechanisms

Drug targets:

  • Polyenes: Target ergosterol directly

  • Azoles: Target ergosterol biosynthetic enzyme (Erg11)

  • Pyrimidine analogues: Block DNA/RNA synthesis

  • Echinocandins: Target glucan synthase (Fks1) - Cryptococcus shows inherent resistance

Resistance mechanisms:

  • Genetic plasticity (aneuploidy, hypermutator strains, transposon movement)

  • Overexpression or alteration of drug target

  • Inactivation of proteins required for drug engagement

  • Increased expression of efflux pumps

  • Capsule formation and cell wall thickening

  • Melanin production

  • Formation of titan cells

Special Note: Cryptococcus gattii

Key difference:

  • Can infect immunocompetent people (unlike C. neoformans which primarily affects immunocompromised)

  • Produces blue color on CGB agar

Summary Flow Chart

Environment (pigeon droppings) → Inhalation → Pulmonary alveoli → Survival (glucosylceramide synthase) → Phagocytosis by macrophages → Latency in lung lymph nodes → Dissemination (immunocompromised) → CNS invasion (neurotropism, metalloproteinases, urease) → Blood-brain barrier penetration → Cryptococcal meningitis